BridgeMD
Is botulinum toxin injection better than corticosteroid injection in the management of persistent post-surgical pain
EU CTIS ID: 2024-518954-18-01
What this study is testing
Test the null hypothesis that Botox is inferior to corticosteroids in treating post-surgical scar pain
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Male and Female patients over 18 years of age with a diagnosis of persistent post-surgical pain (pain lasting more than 3 months after the original surgical treatment) who attend the pain clinic outpatient department in MMUH that can provide written informed consent.
You likely can't join if
- Absence of informed written consent, pre-existing infection at block site, severe coagulopathy, allergy to local anaesthesia, pre-existing dementia [because of need to co-operate in completing questionnaires after the procedure].
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.